A key member of the team that developed bone marrow transplantation as a successful treatment for leukemia nearly half a century ago, Frederick Appelbaum, MD, was honored on Feb. 18 with a Lifetime Achievement Award from the American Society for Transplantation and Cellular Therapy at the organization’s annual meeting in Orlando, Florida.
As severe shortages of fludarabine drag on and prices soar, transplant centers are struggling to cope. The drug is an essential component of stem-cell transplants for some blood cancers.
American Society for Transplantation and Cellular Therapy (ASTCT) is pleased to announce that Owhofasa Agbedia, MD, MPH, has been selected by the American.